# Jade Therapeutics, Inc. — Form D

Jade Therapeutics, Inc. of SALT LAKE CITY, X1, a company, filed a Form D exempt-offering notice with the SEC on 2014-12-31. The offering totals $800K. Industry: Biotechnology.

## Offering

- Filed: 2014-12-31
- Form: D
- Accession: 0001591214-14-000002
- Industry: Biotechnology
- Exemptions: 04
- Total offering: $800K
- Remaining: $800K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-231146

## Issuer

- Name: Jade Therapeutics, Inc.
- CIK: 0001591214
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 675 ARAPEEN DR., SUITE 302, SALT LAKE CITY, X1, 84108-1228
- Phone: 646-918-7479

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Arthur Klausner | Director | Bedford, NY |
| Randall Olson | Director | Salt Lake City, UT |
| DINESH PATEL | Director | Bothell, WA |
| Mary Jane Rafii | Director | Wilton, CT |
| Barbara Wirostko | Director | Dedham, MA |
| Arthur Klausner | Executive Officer | Bedford, NY |
| Mary Jane Rafii | Executive Officer | Wilton, CT |
| Barbara Wirostko | Executive Officer | Dedham, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2013-11-08](https://search.stillhousedata.com/formd/0001591214-13-000001) | D | $600K | — |

## More

- [CIK 1591214 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1591214&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001591214-14-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.